1. Home
  2. NLSP vs USEA Comparison

NLSP vs USEA Comparison

Compare NLSP & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • USEA
  • Stock Information
  • Founded
  • NLSP 2015
  • USEA 2004
  • Country
  • NLSP Switzerland
  • USEA Greece
  • Employees
  • NLSP N/A
  • USEA N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • USEA Marine Transportation
  • Sector
  • NLSP Health Care
  • USEA Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • USEA Nasdaq
  • Market Cap
  • NLSP 12.4M
  • USEA 10.5M
  • IPO Year
  • NLSP 2021
  • USEA N/A
  • Fundamental
  • Price
  • NLSP $2.68
  • USEA $1.49
  • Analyst Decision
  • NLSP
  • USEA Strong Buy
  • Analyst Count
  • NLSP 0
  • USEA 1
  • Target Price
  • NLSP N/A
  • USEA $6.00
  • AVG Volume (30 Days)
  • NLSP 325.4K
  • USEA 200.9K
  • Earning Date
  • NLSP 07-07-2025
  • USEA 08-05-2025
  • Dividend Yield
  • NLSP N/A
  • USEA 2.66%
  • EPS Growth
  • NLSP N/A
  • USEA N/A
  • EPS
  • NLSP N/A
  • USEA N/A
  • Revenue
  • NLSP N/A
  • USEA $42,595,000.00
  • Revenue This Year
  • NLSP N/A
  • USEA N/A
  • Revenue Next Year
  • NLSP N/A
  • USEA $11.62
  • P/E Ratio
  • NLSP N/A
  • USEA N/A
  • Revenue Growth
  • NLSP N/A
  • USEA N/A
  • 52 Week Low
  • NLSP $1.30
  • USEA $1.00
  • 52 Week High
  • NLSP $16.00
  • USEA $2.78
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 62.59
  • USEA 55.20
  • Support Level
  • NLSP $2.19
  • USEA $1.40
  • Resistance Level
  • NLSP $2.54
  • USEA $1.57
  • Average True Range (ATR)
  • NLSP 0.19
  • USEA 0.13
  • MACD
  • NLSP -0.01
  • USEA 0.00
  • Stochastic Oscillator
  • NLSP 57.89
  • USEA 29.17

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About USEA United Maritime Corporation

United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.

Share on Social Networks: